A cost-effectiveness analysis of onabotulinumtoxinA for overactive bladder in patients who are inadequately managed with anticholinergic medications in Spain.

Errando-Smet C1, Larrea G2, Cidre J3, Loveman C4, Khalaf K5, Aracil J6, Stanisic S7, Lister J8

Abstract Category

Female Lower Urinary Tract Symptoms (LUTS) / Voiding Dysfunction

Abstract 330
Lower Urinary Tract Symptoms in Women 1
Scientific Podium Poster Session 20
Wednesday 22nd October 2014
15:30 - 15:35
Room 3
Overactive Bladder Incontinence Detrusor Overactivity Urgency Urinary Incontinence
1. Fundació Puigvert, Barcelona, Spain, 2. Hospital Donostia, Gipuzkoa, Spain, 3. Hospital Universitario Ramón y Cajal, Madrid, Spain, 4. Allergan Limited, Marlow, UK, 5. Allergan, Inc., Irvine CA, USA, 6. Allergan España, Madrid, Spain, 7. La-ser Analytica, Milano, Italy, 8. La-ser Analytica, Lörrach, Germany
Presenter
C

Carlos Errando-Smet

Links

Abstract

28/03/2024 00:24:35